NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Badrinath Konety
University of Minnesota Twin Cities - Minneapolis / United States
Medical and Health Sciences / Urology
AD Scientific Index ID: 4679120
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Badrinath Konety's MOST POPULAR ARTICLES
1-)
Early detection of prostate cancer: AUA Guideline HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ... The Journal of urology 190 (2), 419-426, 2013 12242013
2-)
Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline SS Chang, SA Boorjian, R Chou, PE Clark, S Daneshmand, BR Konety, ... The Journal of urology 196 (4), 1021-1029, 2016 8872016
3-)
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial DJ Parekh, IM Reis, EP Castle, ML Gonzalgo, ME Woods, RS Svatek, ... The Lancet 391 (10139), 2525-2536, 2018 4642018
4-)
Active surveillance for the management of prostate cancer in a contemporary cohortMA Dall\'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ...Cancer: Interdisciplinary International Journal of the American Cancer …, 20084722008
5-)
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 studyAV Balar, AM Kamat, GS Kulkarni, EM Uchio, JL Boormans, M Roumiguié, ...The Lancet Oncology 22 (7), 919-930, 20214102021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept